跳至主要内容
临床试验/CTRI/2025/08/092258
CTRI/2025/08/092258尚未招募2 期

A Clinical comparative study on the efficacy of Meshroma Mashyadi Taila Varti and Jatyadi Taila Varti in the management of Nadi vrana w.s.r. to Sinus.

Prabudh Kumar Praveen1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年8月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
The clinical efficacy of Mesha Roma mashyadiTaila varti will reduced the sign and symptoms of Nadi Varana in 30 days

研究概览

简要总结

This study is randomized single blind parallel group in Dayanand Ayurvedic Medical College and Hospital Siwan Trial comparing the clinical efficacy of Mesha Roma Mashyadi Taila Varti and Jatyadi Taila Varti on every 3rd day upto 30 days or till the tract heal 100 patients with sign and symptoms of Nadi Vrana will be conducted in Dayanand Ayurvedic Medical College and Hospital Siwan  India The primary outcome measures will be on the basis of clinical efficacy of sign and symptoms of Nadi vrana in 30 days and assess parameters every 3rd day upto to 30 days or tract will be healed

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients having sign and symptoms of Nadi vrana Sinus tract less than 5 centimeters.

排除标准

  • Patients having diabetes mellitus, neoplastic Sinus,actinomycosis, tuberculosis, H.I.V, Hepatitis, CA, Major systemic illness, Hypertension, Anaemia (Hb less than 8mg/dl.
  • Sinus with more than two opening.
  • Length of Sinus tract more than 5 cms.

结局指标

主要结局

The clinical efficacy of Mesha Roma mashyadiTaila varti will reduced the sign and symptoms of Nadi Varana in 30 days

时间窗: The clinical efficacy of Mesha Roma mashyadiTaila varti will reduced the sign and symptoms of Nadi Varana in 30 days

次要结局

  • Nill(Nill)

研究者

发起方
Prabudh Kumar Praveen
申办方类型
Other [individual ]
责任方
Principal Investigator
主要研究者

Prabudh kumar Praveen

Dayanand Ayurvedic Medical college and Hospital

研究点 (1)

Loading locations...

相似试验